A high level of tumor CD8+ T-cell infiltration reportedly correlates with worse prognosis in patients with ccRCC (24), possibly explaining the worse prognosis observed in patients with higher risk scores. This evidence concerns the gene CD8A and nonpapillary renal cell carcinoma.